MolNFT v1 · #166466 · protein

Serendipitous discovery of aryl boronic acids as beta-lactamase inhibitors

6UQT: “Serendipitous discovery of aryl boronic acids as beta-lactamase inhibitors”. X-ray diffraction, 2 ligands (QFS, CL), 3 pockets (best druggability 0.61). MolNFT v1 #166466 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB: 6UQT
Type: protein
Length: 363 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: Q541D8
Ligands: QFS, CL
Pockets: 3 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 22% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	363	43% helix, 22% strand	Q541D8

Ligands and binding sites

QFS · 2-hydroxyethyl hydrogen (3-methoxyphenyl)boronate · ligand · chains A
CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	314	0.61	0.79	41	QFS, CL
2	62	0.33	0.77	16	empty
3	63	0.32	0.75	16	empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

6UQT · Serendipitous Discovery of Aryl Boronic Acids as beta-Lactamase Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt Q541D8
Elsewhere: RCSB PDB 6UQT · PDBe 6UQT · UniProt Q541D8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.